Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin N and Huminsulin Basal
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2017
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Julphar Gulf Pharmaceutical Industries
- 24 Jul 2017 Planned End Date changed from 10 Feb 2017 to 30 Oct 2017.
- 24 Jul 2017 Planned primary completion date changed from 1 Jan 2017 to 30 Oct 2017.
- 24 Jul 2017 Status changed from completed to active, no longer recruiting.